Last reviewed · How we verify
NCT04575298
Acceptability and Tolerance Study of an Amino Acid Formula with HMOs
trial testing Acceptability, tolerance study for an infant formula with human milk oligosaccharides in Infant Development in 10 participants. Terminated before completion.
22 December 2020
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 10 |
| Start date | 12 October 2019 |
| Primary completion | 22 December 2020 |
| Estimated completion | 22 December 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Acceptability, tolerance study for an infant formula with human milk oligosaccharides
Conditions studied
- Infant Development — all drugs for Infant Development →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
Adults 1 Month to 12 Months, any sex, with Infant Development. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the acceptability (including gastrointestinal tolerance and compliance) of a hypoallergenic amino acid infant formula with HMOs for the dietary management of cows' milk allergy in infants less than 12 months of age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04575298
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infant Development
Currently open trials in the same condition.
- NCT06536296 — The Impact of Music Medicine on Preterm Brain Development and Behavior · NA · recruiting
- NCT06892483 — Breastmilk in Response to a Bout of Exercise · recruiting
- NCT06479278 — Talk With Me Baby to Enhance the Early Home Language Environment · NA · recruiting
- NCT06396520 — Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy · recruiting
- NCT06332521 — Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment · recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04575298 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04575298.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing